Head-to-head · WeighScore
AgelessRx vs Kin Meds
By GLP-1 ScorecardUpdated
Score comparison
AgelessRx has the higher recorded score — 84.3/100 to 69.1/100.
AgelessRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Conventional and microdose GLP-1 programs with continuing care; branded prescriptions involve a separate pharmacy payment.
Before you choose
AgelessRx does not publish a semaglutide price, so its AgelessRx review sets out what it does disclose, while the Kin Meds review explains the conditions attached to Kin Meds's figure. The semaglutide cost page compares published rates across the field. Ask AgelessRx for a written total before treating either one as the cheaper choice.
If neither one fits, AgelessRx vs Klarity Health and Allara Health vs Kin Meds compare each of them with another graded program, and the list of alternatives to AgelessRx ranks the programs closest to AgelessRx on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the Bodybuilding Health+ review covers one graded close to these two, at 78.1/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | AgelessRx | Kin Meds |
|---|---|---|
| WeighScore | 84.3/100 | 69.1/100 |
| Grade | B | C |
| Site position | #17 | #147 |
| Semaglutide | Not verified (current medication-specific quote required) | Wegovy advertised from $149/mo; selected total unverified |
| Tirzepatide | Microdose: $109 first month, then $318 every 2 months ($159/mo); full-dose quote required | Zepbound advertised from $149/mo; selected total unverified |
| Coverage | Advertises US service; confirm treatment-specific state availability | Coverage not published |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Site position #17 · B
Strengths
- Conventional and lower-dose GLP-1 programs advertised
- Wegovy pens and oral-tablet consultations advertised
- Continuing messaging and check-ins advertised
What to consider
- Conventional medication-specific monthly quotes not verified
- Microdose introduction renews as a two-month charge
- Branded medication has a separate pharmacy bill
- Treatment-specific state eligibility and assigned dispenser need confirmation
FDAWarning letter issued to Kin Meds in February 2026. See the FDA warning-letter database.
Strengths
- Lists Wegovy and Zepbound on separate product pages
- Describes subscription cancellation through the patient account before shipment
What to consider
- The advertised starting price leaves the selected bill and insurance costs unverified
- The policy treats charged orders as final after carrier handoff
- Confirm service availability and dispensing pharmacy for your prescription
- FDA issued Kin Meds a warning letter in February 2026; the letter is public in FDA's warning-letter database
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.